Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Liquid Biopsy Market Expected to Grow Between 2025 And 2029?

The market size for liquid biopsy has experienced rapid expansion in the past years. It is set to rise from $1.25 billion in 2024 to $1.46 billion in 2025, showcasing a compound annual growth rate (CAGR) of 16.4%. The significant growth during the historic period is due to factors like progress in cancer research, the non-invasive nature of the test, personalized medical approach, regulatory authorizations, as well as early cancer detection efforts.

What Growth Rate Is Anticipated for the Liquid Biopsy Market in the Coming Years?

In the coming years, the liquid biopsy market is predicted to experience swift expansion. The market valuation is expected to reach $2.76 billion by 2029, growing at a compound annual growth rate (CAGR) of 17.2%. This predicted growth during the forecast period is due to a range of factors including the broadening of applications, cancer surveillance, the upsurge of new technologies, companion diagnostics, and biomarker discovery. Key trends predicted for the forecast period encompass cancer detection and monitoring, therapeutic scrutiny, monitoring of minimal residual disease (MRD), and the application of liquid biopsy in non-oncological areas.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2815&type=smp

Who Are the Leading Companies in the Liquid Biopsy Market?

Major companies operating in the liquid biopsy market include QIAGEN NV, Roche Diagnostics Ltd., Bio-Rad Laboratories Inc., Myriad Genetics Inc., Guardant Health Inc., Thermo Fisher Scientific Inc., Menarini Silicon Biosystems, Biocept Inc., Janssen Diagnostics LLC, Trovagene Inc., Fraunhofer-Gesellschaft, MDX Health SA, Agilent Technologies Inc., Illumina Inc., Oxford Nanopore Technologies Ltd., Quantum Biosystems Inc., Menarini Silicon Biosystems Inc., Pathway Genomics Corporation, Sysmex Corporation, Janssen Global Services LLC, Natera Inc., ANGLE Plc, Bio Techne Corp, Biodesix Inc., CellMax Inc., CIRCULOGENE, Exact Sciences Corporation, Epic Sciences Inc., Exosome Diagnostics Inc., GRAIL Inc., Guardant Health AMEA, Inivata Ltd., NIPD Genetics, Oncocyte Corporation, Personal Genome Diagnostics Inc., RainDance Technologies Inc., Thrive Earlier Detection Corp.

What Are the Key Drivers of the Liquid Biopsy Market?

The liquid biopsy market’s growth is propelled by government funding specifically targeted toward improving cancer detection. This funding aids scientists in pioneering drugs, diagnosing, and treating illnesses, including cancer. For instance, a medical research entity based in the U.S., the National Institute of Health (NIH), was allocated a budget of $46.6 billion in 2022, with $6.9 billion received by the National Cancer Institute (NCI), a U.S cancer research institute, specifically for pushing the boundaries of cancer research. Consequently, such government funding serves to bolster the liquid biopsy market’s development.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2815&type=smp

What Are the Key Market Segments in the Liquid Biopsy Industry?

The liquid biopsy market covered in this report is segmented –

1) By Product: Assays Kits, Instruments, Services

2) By Clinical Application: Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring Orthopedics

3) By End User: Reference Laboratories, Hospitals and Physician Laboratories, Academic and Research Centers

Subsegments:

1) By Assays Kits: cfDNA Assays, ctDNA Assays, Exosome-based Assays, RNA-based Assays, Protein-based Assays

2) By Instruments: PCR Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments, Mass Spectrometry Instruments

3) By Services: Testing Services, Data Analysis Services, Laboratory Services, Custom Assay Development Services

What Are the Latest Trends in the Liquid Biopsy Market?

Businesses are quickly embracing new market trends and prioritizing the introduction of innovative products. This approach aims to meet the growing demand for liquid biopsy products and services, enhance their revenues, and maintain an advantage over competitors. For instance, in June 2023, Laboratory Corporation of America Holdings, a healthcare company based in the US, introduced a liquid biopsy test named Labcorp Plasma Focus. This test was designed to detect cancer-related biomarkers in people with advanced or metastatic solid tumours. The analysis looks at the cell-free DNA (cfDNA) in a patient’s bloodstream to create a genomic profile of their tumour. As a result, oncologists can improve patient healthcare management by developing personalized, accurately targeted treatment plans. Therefore, investment in developing sophisticated products in the liquid biopsy market is a key strategy for companies.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

What Are the Key Regional Markets in the Liquid Biopsy Industry?

North America was the largest region in the liquid biopsy market in 2023. Western Europe was the second largest region in the liquid biopsy market. The regions covered in the liquid biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2815

This Report Delivers Insight On:

1. How big is the liquid biopsy market, and how is it changing globally?

2. Who are the major companies in the liquid biopsy market, and how are they performing?

3. What are the key opportunities and risks in the liquid biopsy market right now?

4. Which products or customer segments are growing the most in the liquid biopsy market?

5. What factors are helping or slowing down the growth of the liquid biopsy market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.